Not applicableStudy completedNCT02385604What this trial is testingThe Predictive Value of CT-PET in Esophageal CancerWho this might be right forEsophageal Neoplasms St. James's Hospital, Ireland 250
Large-scale testing (Phase 3)Active Not RecruitingNCT06356311What this trial is testingEvaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)Who this might be right forGastroesophageal Cancer Merck Sharp & Dohme LLC 450
Large-scale testing (Phase 3)Study completedNCT03143153What this trial is testingEvaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinWho this might be right forVarious Advanced Cancer Bristol-Myers Squibb 970
Testing effectiveness (Phase 2)Looking for participantsNCT07341737What this trial is testingSL-28 for Advanced Solid TumoursWho this might be right forHead & Neck CancerPancreas CarcinomaPancreas Cancer, Metastatic+15 more Second Life Therapeutics 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05945823What this trial is testingPhase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid TumorsWho this might be right forLocally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal CancerEsophageal AdenocarcinomaEsophageal Squamous Cell Cancer+2 more Taiho Oncology, Inc. 53
Not applicableNot Yet RecruitingNCT04616040What this trial is testingA Real-world Study Evaluating the Usage of Camrelizumab in Chinese Patients With Advanced Esophageal CancerWho this might be right forEsophageal Cancer Peking University 1,030
Early research (Phase 1)Looking for participantsNCT04900818What this trial is testingStudy of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsWho this might be right forSolid TumorAdvanced CancerMetastatic Cancer+5 more I-Mab Biopharma US Limited 330
Testing effectiveness (Phase 2)Study completedNCT02552121What this trial is testingTisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsWho this might be right forOvary CancerCervix CancerEndometrium Cancer+4 more Seagen Inc. 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT04757363What this trial is testingNivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric CancerWho this might be right forEsophagogastric CancerHER2-Negative Memorial Sloan Kettering Cancer Center 39
Not applicableEnded earlyNCT02296528What this trial is testingSafety and Efficacy of the Swallow Expansion Device (SED) for Improvement of Swallowing in PatientsWho this might be right forOropharyngeal Dysphagia (OPD)Dysphagia Peter Belafsky, MD 4
Not applicableUnknownNCT00220077What this trial is testingDetermination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal CancerWho this might be right forOesophageal Cancer Royal Marsden NHS Foundation Trust 400
Early research (Phase 1)Ended earlyNCT04187872What this trial is testingLITT and Pembrolizumab in Recurrent Brain MetastasisWho this might be right forMelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more University of Florida 10
Not applicableWithdrawnNCT04985357What this trial is testingDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWho this might be right forStage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more Travera Inc
Testing effectiveness (Phase 2)Study completedNCT03993353What this trial is testingTadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck CancerWho this might be right forHead and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Carcinoma+9 more University of California, San Diego 7
Large-scale testing (Phase 3)UnknownNCT02611700What this trial is testingNimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinomas Biotech Pharmaceutical Co., Ltd. 504
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Early research (Phase 1)Looking for participantsNCT05983432What this trial is testingEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid TumorsWho this might be right forNon Small Cell Lung CancerEsophageal CancerSmall Cell Lung Cancer+7 more SystImmune Inc. 540
Testing effectiveness (Phase 2)Active Not RecruitingNCT07142421What this trial is testingTrifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) First Affiliated Hospital of Zhejiang University 35
Testing effectiveness (Phase 2)Looking for participantsNCT07481058What this trial is testingKC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal CancerWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Beijing Konruns Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT05619016What this trial is testing[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid TumorsWho this might be right forEsophageal NeoplasmsGastric Neoplasms MalignantBreast Cancer+1 more Karolinska University Hospital 72